DK1069892T3 - Fugtighedsaktiverbart terapeutisk system - Google Patents

Fugtighedsaktiverbart terapeutisk system

Info

Publication number
DK1069892T3
DK1069892T3 DK99914523T DK99914523T DK1069892T3 DK 1069892 T3 DK1069892 T3 DK 1069892T3 DK 99914523 T DK99914523 T DK 99914523T DK 99914523 T DK99914523 T DK 99914523T DK 1069892 T3 DK1069892 T3 DK 1069892T3
Authority
DK
Denmark
Prior art keywords
skin
mucous membrane
active agent
activating agent
therapeutic system
Prior art date
Application number
DK99914523T
Other languages
Danish (da)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1069892T3 publication Critical patent/DK1069892T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99914523T 1998-03-30 1999-03-18 Fugtighedsaktiverbart terapeutisk system DK1069892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814087A DE19814087A1 (de) 1998-03-30 1998-03-30 Feuchtigkeitsaktivierbares therapeutisches System
PCT/EP1999/001802 WO1999049853A1 (de) 1998-03-30 1999-03-18 Feuchtigkeitsaktivierbares therapeutisches system

Publications (1)

Publication Number Publication Date
DK1069892T3 true DK1069892T3 (da) 2002-12-02

Family

ID=7862905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99914523T DK1069892T3 (da) 1998-03-30 1999-03-18 Fugtighedsaktiverbart terapeutisk system

Country Status (13)

Country Link
US (1) US7175853B1 (no)
EP (1) EP1069892B1 (no)
JP (1) JP4252212B2 (no)
KR (1) KR100550886B1 (no)
AT (1) ATE221774T1 (no)
AU (1) AU3331299A (no)
CA (1) CA2326662C (no)
DE (2) DE19814087A1 (no)
DK (1) DK1069892T3 (no)
ES (1) ES2182507T3 (no)
NO (1) NO20004835L (no)
PT (1) PT1069892E (no)
WO (1) WO1999049853A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
DE102007041734A1 (de) * 2006-12-20 2008-06-26 Tesa Ag Repulpierbare Klebmassen
WO2009107478A1 (ja) * 2008-02-27 2009-09-03 久光製薬株式会社 貼付剤及び包装体
EP2258369B1 (en) * 2008-02-27 2015-04-08 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
US20120090275A1 (en) * 2009-04-24 2012-04-19 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch-containing package bag and method for storing adhesive patch
CN102361638B (zh) * 2009-05-21 2013-07-17 久光制药株式会社 经皮吸收制剂
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
KR101737960B1 (ko) * 2009-11-12 2017-05-19 니혼 유니버서티 외용 의약 조성물
ES2670227T3 (es) * 2009-12-22 2018-05-29 Luye Pharma Ag Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
CA2786443C (en) 2010-01-14 2018-12-11 Novartis Ag Use of an adrenal hormone-modifying agent
AU2011248904B2 (en) 2010-04-30 2014-02-27 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
EP2716287B1 (en) * 2011-05-31 2017-11-15 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing adhesive skin patch and packaged product thereof
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
US9481777B2 (en) 2012-03-30 2016-11-01 The Procter & Gamble Company Method of dewatering in a continuous high internal phase emulsion foam forming process
CN104797245B (zh) 2012-11-02 2018-05-04 帝国制药美国公司 丙炔基氨基茚满透皮组合物
WO2015137872A1 (en) * 2014-03-13 2015-09-17 Innovator Skåne Ab Tubular or sheet-shaped drug delivery system
EP3573604A4 (en) 2016-12-29 2020-07-22 Pure Ratios Holdings, Inc. MODULAR TRANSDERMAL ADMINISTRATION SYSTEM AND ASSOCIATED MANUFACTURING AND USE PROCEDURES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
AT392587B (de) * 1988-03-03 1991-04-25 Sandoz Ag Pharmazeutische zusammensetzung enthaltend phenylcarbamate
DE3905050A1 (de) 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
DE3905051A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3910543A1 (de) 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof

Also Published As

Publication number Publication date
CA2326662C (en) 2007-01-16
PT1069892E (pt) 2002-12-31
US7175853B1 (en) 2007-02-13
ES2182507T3 (es) 2003-03-01
EP1069892B1 (de) 2002-08-07
KR20010042173A (ko) 2001-05-25
ATE221774T1 (de) 2002-08-15
DE59902270D1 (de) 2002-09-12
KR100550886B1 (ko) 2006-02-10
CA2326662A1 (en) 1999-10-07
DE19814087A1 (de) 1999-10-14
JP2002509879A (ja) 2002-04-02
EP1069892A1 (de) 2001-01-24
JP4252212B2 (ja) 2009-04-08
WO1999049853A1 (de) 1999-10-07
NO20004835D0 (no) 2000-09-26
AU3331299A (en) 1999-10-18
NO20004835L (no) 2000-09-26

Similar Documents

Publication Publication Date Title
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
WO2002085447A3 (en) Microprojection array having a beneficial agent containing coating
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
PT974350E (pt) Preparacao contendo tranilast para aplicacao externa e metedo para a sua producao
BRPI0416044A (pt) sistema e método para distribuição transdérmica
TW201412342A (zh) 應用微囊化亞硝酸鹽和酸化水凝膠的延時產生一氧化氮的系統和方法
US4039664A (en) Topical griseofulvin composition and method
BR0210994A (pt) Compostos farmacêuticos e de diagnósticos contendo nanopartìculas úteis para tratamento de tecidos e células
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
PORZIO et al. EFFICACY OF A NEW TOPICAL GEL-SPRAY FORMULATION OF KETOPROFEN LYSINE SALT IN THE RAT: PERCUTANEOUS PERMEATIONIN VITROANDIN VIVOAND PHARMACOLOGICAL ACTIVITY
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
HUP9902032A2 (hu) Peszticid készítmény
KR960021054A (ko) 위장질환 치료제용 쑥추출물
US4476115A (en) Analgesic composition and method of treating subdermal pain
NO20000376D0 (no) Transdermalt terapeutisk system for frigiving av virkestoff gjennom huden inn i en organisme og fremgangsmåte for påfoering på huden
DK1019037T3 (da) Lægemiddel indeholdende delta-aminolevulinsyre
JPH11302145A (ja) 日やけ止め化粧料
BR0015422A (pt) Formulações de droga de liberação prolongada
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
RU2181584C1 (ru) Стимулятор роста волос
IT1158029B (it) Preparato per ridurre traumi dei tessuti in esseri umani o animali e procedeminto per la sua produzione
UA82472C2 (uk) Трансдермальна фармацевтична композиція, що містить ацетилсаліцилову кислоту, для лікування кальцифікації
RU2002126632A (ru) Водная лекарственная композиция для лечения заболеваний кожи